<DOC>
	<DOCNO>NCT02811133</DOCNO>
	<brief_summary>This open trial seek determine safety tolerability use inositol child adolescent bipolar disorder comorbid anxiety disorder exploration efficacy dose response .</brief_summary>
	<brief_title>Inositol Comorbid Anxiety Children Adolescents With Bipolar Disorder</brief_title>
	<detailed_description>Anxiety disorder common comorbidity among child adolescent bipolar disorder . Treatment standard pharmacologic agent may worsen mood problem lead drug dependency . Inositol show benefit bipolar depression adult . This open multi-case control study . The investigator enroll 20 child adolescent age 8-17 treated Child Adolescent Bipolar Services ( CABS ) Western Psychiatric Institute Clinic . A subject involvement 14 week , include initial titration supplement , maintenance , taper . Primary outcome include standard measure mood anxiety . Also , physiologic measure include body mass index bedside glucose follow .</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Anxiety Disorders</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<criteria>1 . DSMV ( Diagnostic Statistical Manual5th Ed . ) diagnosis bipolar disorder , determine KSADS ( Kiddie Schedule Affective Disorders Schizophrenia ) . 2 . DSMV diagnosis anxiety disorder separation anxiety disorder , generalize anxiety disorder , social phobia , panic disorder , determine KSADS . 3 . On stable dose psychotropic medication least one month , viz new medication add last month . 4 . At least moderate severity anxiety symptom determine score Pediatric Anxiety Rating Scale ( PARS ) . 1 . Presence prominent diarrhea . 2 . Diagnosis diabetes mellitus . 3 . Presence active suicidal ideation psychosis . 4 . Weight le 20 kg . 5 . Known pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>8 Years</minimum_age>
	<maximum_age>17 Years</maximum_age>
	<verification_date>June 2016</verification_date>
	<keyword>inositol</keyword>
</DOC>